NEW YORK, NY – April 18th, 2016 -- Investors Hub NewsWire – http://www.BroadStreetAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.Broadstreetalerts.com is often on the lookout for either large investor relations campaigns being deployed or stocks gaining momentum.
 
To subscribe by phone and receive messages directly to your mobile phone in real time, text keyword "Alerts" to 25827.

We believe the following companies could be getting some attention in the near future follow the links for the full report.
 
Skyline Medical Inc. (NASDAQ: SKLN)
Skyline Medical Inc. has a fully automated, patented, and FDA cleared surgical fluid disposal devices - the STREAMWAY System - that virtually eliminates operating room worker’s exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Full report- http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
 
 
Strikeforce Technologies, Inc. (OTCMKT: SFOR)
StrikeForce Technologies provides a suite of online products that help prevent cyber theft and data breaches by protecting customers, employees and partners in real time at every vulnerable point. Its products prevent fraud during account creation, account access, transactions and changes, and transaction verification, saving businesses millions of dollars, offering new levels of customer protection, and strengthening their brand names. Full report- http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
 
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Full report-  http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
 
Amarin Corp. Plc (NASDAQ: AMRN)
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The companys lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland. Full report- http://broadstreetalerts.com/nkln-nwbo-amrn-sfor-reports/
 
 
About Broad Street Alerts
We make the connection between sophisticated investors and high quality micro and small cap companies. An issuer of reports that provide a straightforward assessment of the profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements

Compliance Procedure   
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only.  A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.

Source: Broad Street Alerts

Contact: editor@broadstreetalerts.com


Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Amarin Charts.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Amarin Charts.